Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian ...
Key market opportunities include increased diagnosis of multicentric Castleman disease, precision immunotherapy, and expansion of specialty clinics. Growth is driven by targeted IL-6 therapies, rising ...
A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...
The monarch has spent the afternoon speaking with healthcare professionals and chemotherapy patients before unveiling a ...
Stocktwits on MSN
IBRX stock can't shake FDA delay overhang: Founder touts Saudi and Greece progress with Anktiva as bright spots
Soon-Shiong highlighted that ImmunityBio’s Quilt 3005 immunotherapy is already approved by the Saudi FDA. ・Investors are closely watching the FDA’s ongoing review of ImmunityBio’s resubmitted BLA for ...
When I began my career in Chicago, USA, my research was centred on asthma, a condition that affects so many children every ...
Scientists may have discovered a surprising new way to help the immune system fight blood cancer using a vitamin that many ...
A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...
Dr. Leal discusses the updated NCCN guidelines recommending VGCC antibody testing for patients with suspected neurologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results